ReWalk Robotics Ltd. (NASDAQ:RWLK) shares traded down 2.5% during mid-day trading on Thursday . The company traded as low as $6.61 and last traded at $6.68, with a volume of 114,324 shares changing hands. The stock had previously closed at $6.85.

A number of research analysts have recently issued reports on the stock. Jefferies Group reiterated a “buy” rating and issued a $16.00 target price on shares of ReWalk Robotics in a research note on Sunday, May 8th. Zacks Investment Research raised shares of ReWalk Robotics from a “sell” rating to a “hold” rating in a report on Thursday, April 28th. Canaccord Genuity reissued a “buy” rating on shares of ReWalk Robotics in a report on Sunday. Finally, Piper Jaffray Cos. initiated coverage on shares of ReWalk Robotics in a report on Friday, July 15th. They issued an “overweight” rating and a $10.00 price target for the company. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $12.80.

The company’s market capitalization is $82.26 million. The firm’s 50 day moving average price is $6.69 and its 200 day moving average price is $8.48.

ReWalk Robotics (NASDAQ:RWLK) last issued its quarterly earnings data on Thursday, August 4th. The medical device company reported ($0.64) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.53) by $0.11. The company earned $0.82 million during the quarter, compared to analyst estimates of $1.95 million. ReWalk Robotics’s revenue for the quarter was up 34.4% compared to the same quarter last year. On average, equities research analysts expect that ReWalk Robotics Ltd. will post ($2.34) EPS for the current year.

In related news, major shareholder Scp Vitalife Partners (Israel) sold 4,772 shares of the stock in a transaction that occurred on Friday, June 3rd. The stock was sold at an average price of $7.89, for a total value of $37,651.08. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Wayne Weisman sold 16,148 shares of the stock in a transaction that occurred on Friday, May 20th. The stock was sold at an average price of $9.09, for a total value of $146,785.32. The disclosure for this sale can be found here.

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk. The Company offers ReWalk, an exoskeleton that uses its tilt-sensor technology, and an on-board computer and motion sensors to drive motorized legs that power movement.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.